HKU Scholars Hub: Browsing DSpace

Browsing "Li Ka Shing Faculty of Medicine" by Author wong, h

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 43 next >

Title	Author(s)	Issue Date
A phase II study of neoadjuvant chemotherapy using combined taxane, anthracycline, and cyclophosphamide in high risk HER2-negative locally advanced breast cancer Proceeding/Conference:GBCC / IBCS 2015	Chiu, WYJ Leung, RCY Suen, TKD Chen, THC Chow, CYL Kwok, G Wong, H Cheung, P Yau, TCC Kwong, A	2015
A prospective study on the predictive and prognostic value of baseline biomarker expressions in locoregionally advanced rectal cancer treated with neoadjuvant chemoradiation using capecitabine Proceeding/Conference:Annual Scientific Meeting of Hong Kong College of Radiologists, HKCR 2016	Lam, KO Lo, AWI Wong, H Choi, CW Choy, TS Lee, VHF Lam, TC So, TH Fu, CC Shek, WH Leung, TW	2016
Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy Journal:Anti-Cancer Agents in Medicinal Chemistry	Leung, R Lang, B Wong, H Chiu, J Wan, KY Shek, T Woo, YC Lo, CY Yau, T	2012
Avian influenza in Hong Kong 1997-2002 Proceeding/Conference:Avian Diseases	Sims, LD Ellis, TM Liu, KK Dyrting, K Wong, H Peiris, M Guan, Y Shortridge, KF	2003
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy Journal:Postgraduate Medical Journal	Chiu, JW Leung, R Tang, V Cheuk, WY Lo, J Kwok, GW Wong, H Suen, D Cheung, P Wong, TT Yau, T Kwong, A	2019
Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer Journal:Medical Oncology	Wong, H Lau, S Leung, R Chiu, J Cheung, P Wong, TT Liang, R Epstein, RJ Yau, T	2012
Colon cancer in a patient with underlying aplastic anemia: A clinical challenge Journal:World Journal of Clinical Oncology	Wong, H Chan, P Yau, TCC	2012
Combination of bevacizumab and erlotinib in the treatment of patients with advanced hepatocellular carcinoma with sorafenib-refractory disease: results of a pilot phase II study Proceeding/Conference:European Journal of Cancer	Yau, T Wong, H Chan, P Yao, T Cheung, TT Fan, ST Poon, RTP	2012
Comparison of clinicopathologic features of invasive lobular carcinoma of the breast with or without associated lobular carcinoma in-situ Proceeding/Conference:European Journal of Cancer	Yau, TCC Wong, H Lau, S Leung, R Chiu, J Wong, TT Liang, R Epstein, RJ Cheung, P	2012
DNA microarray for investigating the mechanism of antitumor action of dendrobim chrysanthum components on hepatoma HepG2 cells Proceeding/Conference:International Conference of Integrative Medicine Against Cancer cum Pong Ding Yuen International Symposium on Traditional Chinese Medicine	Wong, H Ng, TB Ho, KL Lin, X Song, JX Choi, MYM Wong, CK Chung, WY Sze, CW Zhang, Y	2010
Effect of erythropoiesis-stimulating agents on hemoglobin level, fatigue and hospitalization rate in renal palliative care patients Journal:International Urology and Nephrology	Chan, KY Li, CW Wong, H Yip, TPS Sham, MK Cheng, HW Teo, KC Kwok, WC Chan, DTM	2014
Efficacy and safety of single-agent sunitinib in treating advanced hepatocelluar carcinoma patients after sorafenib failure: a prospective, open-label, phase II study Proceeding/Conference:Annals of Oncology	Yau, TCC Leung, RCY Wong, H Chiu, J Chan, P Pang, RWC Fan, ST Poon, RTP	2011
Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: a prospective, open-label, phase II study Proceeding/Conference:Journal of Clinical Oncology	Yau, T Leung, RC Wong, H Chiu, J Chan, P Pang, R Fan, ST Poon, RTP	2011
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma Proceeding/Conference:Oncology	Yau, T Chan, P Wong, H Ng, KK Chok, KSH Cheung, TT Lam, V Epstein, RJ Fan, ST Poon, RTP	2007
Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma Proceeding/Conference:Journal of Clinical Oncology	Wong, H Yau, CC Yao, T Tang, V Chan, P Chiu, J Fan, ST Poon, R	2010
Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors Journal:Acta Oncologica	Wong, H Yau, T Man, CW Epstein, RJ	2009
Inequalities in Psychiatric Morbidity in Hong Kong and Strategies for Mitigation Journal:International Journal of Environmental Research and Public Health	Chan, SM Lam, LCW Law, WY Hung, SF Chan, WC Chen, EYH Chung, GKK Chan, YH Chung, RYN Wong, H Yeoh, EK Woo, J	2022
Integrating molecular mechanisms and clinical evidence in the management of Trastuzumab resistant or refractory Her-2 + metastatic breast cancer Journal:Oncologist	Wong, H Leung, R Kwong, A Chiu, J Liang, R Swanton, C Yau, T	2011
Intramuscular recurrence in a Hepatocellular carcinoma patient with indolent disease course Journal:World Journal of Surgical Oncology	Yau, T Wong, H Chan, P MC, T Poon, RT	2008
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation? Journal:Annals of Surgical Oncology	Wong, H Wong, KP Yau, T Tang, V Leung, R Chiu, J Lang, BHH	2012

Showing results 1 to 20 of 43 next >